"Buying time" has become the most coveted status symbol among the world’s most accomplished men. For Wall Street dealmakers, Silicon Valley founders, and global power brokers, the race is no longer ...

We’ve been talking about this for years now. Personalized medicine. Or precision medicine, if you prefer that term. The idea is simple enough on paper-stop treating patients like averages and start ...

For millions, attention-deficit/hyperactivity disorder (ADHD) is more than an occasional distraction – it’s a persistent neurodevelopmental condition that can ...

Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...

An international research team led by Hiroki Shibuya at RIKEN Center for Biosystems Dynamics Research (BDR) in Japan has ...

Some conservation groups are calling for an effective ban on genetic modification, but others say these technologies are ...

Because the new method can replace a large stretch of defective DNA with a healthy sequence, the same retron-based package can fix any combination of mutations within that stretch of DNA without ...

Scientists at the University of Maryland have uncovered the genetic key behind a rare wheat variety that produces three ...

Researchers discovered the gene that gives a rare wheat variety its unusual “triple-grain” trait. When switched on, the gene ...

(Reuters) -AstraZeneca has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The agreement with Algen gives ...

Biogen has discontinued all gene therapy programs using adeno-associated virus (AAV) capsids, instead shifting resources to modalities that have the highest likelihood of achieving better treatment ...